Summary
The product MasterMed P 100, manufactured by Deus Medical, was analyzed to determine its composition and potency. The sample, identified by batch number NE58368 with a manufacturing date of November 2020, was tested by Janoshik Analytical, a laboratory specializing in pharmaceutical quality testing. The analysis confirmed the presence of Drostanolone Propionate with a measured concentration of 107.58 mg/ml, which exceeds the labeled specification of 100 mg/ml by 7.58%. These findings indicate that the product is slightly overdosed but remains within acceptable limits.
The testing process was initiated on 5 January 2021, with the sample received on 6 January 2021, and the analysis completed on the same day. The sample was submitted and paid for by the reseller, DeusPower.shop, necessitating careful interpretation. This report is published for educational purposes, aiding consumers in making informed decisions regarding the quality and consistency of anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: MasterMed P 100
- Active Ingredient: Drostanolone Propionate
- Batch Number: NE58368
- Manufacture Date: November 2020
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #09571
- Testing Ordered: 5 January 2021
- Sample Received: 6 January 2021
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DeusPower.shop (Reseller)
- Analysis Paid For By: DeusPower.shop (Reseller)
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 107.58 mg/ml
- Accuracy: 107.58% (7.58% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/09571_DQU97VPHT3X6
- Originally Published: https://thinksteroids.com/community/forums/analytical-lab-testing/
Evaluation of Reseller-Funded Testing
This report was submitted and funded by the reseller, DeusPower.shop, necessitating a critical review of the findings. Reseller-funded testing may involve selective sample submission or potential bias in the choice of batch. However, Janoshik Analytical’s history of transparency and consistent methodology lends credibility to these results. For additional validation, cross-referencing with third-party or independent testing is recommended to confirm product quality across multiple batches.
Conclusion
The analysis confirms that MasterMed P 100 by Deus Medical contains 107.58 mg/ml of Drostanolone Propionate, slightly exceeding the labeled specification. While the product is overdosed, it remains within acceptable margins of variance. This report contributes valuable insights for harm reduction and educational purposes, encouraging responsible use and further independent validation to reinforce consumer confidence.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
